For this episode of ZoneCast, I had the opportunity to meet and interview Mike Willand, Co-founder and Chief Technology Officer, and Sergio Aguirre, Co-founder and Chief Executive Officer of Epineuron Technologies.
Epineuron is developing an electrical stimulation device that can increase the speed of recovery of nerve injuries by at least 30%. In 2018, Epineuron received the Breakthrough Device Designation from the Food and Drug Administration (FDA) for its novel Temporary Peripheral Nerve Stimulation System. It is amazing how two young Canadian lads are helping accelerate recovery of nerve injuries.
